191 related articles for article (PubMed ID: 37585449)
1. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation.
Ohta K; Ito M; Chida T; Nakashima K; Sakai S; Kanegae Y; Kawasaki H; Aoshima T; Takabayashi S; Takahashi H; Kawata K; Shoji I; Sawasaki T; Suda T; Suzuki T
PLoS Pathog; 2023 Aug; 19(8):e1011591. PubMed ID: 37585449
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.
Foka P; Dimitriadis A; Karamichali E; Kyratzopoulou E; Giannimaras D; Koskinas J; Varaklioti A; Mamalaki A; Georgopoulou U
Virulence; 2016 Aug; 7(6):679-90. PubMed ID: 27058404
[TBL] [Abstract][Full Text] [Related]
3. The Hepatitis C virus NS5A and core proteins exert antagonistic effects on HAMP gene expression: the hidden interplay with the MTF-1/MRE pathway.
Dimitriadis A; Foka P; Kyratzopoulou E; Karamichali E; Petroulia S; Tsitoura P; Kakkanas A; Eliadis P; Georgopoulou U; Mamalaki A
FEBS Open Bio; 2021 Jan; 11(1):237-250. PubMed ID: 33247551
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
[TBL] [Abstract][Full Text] [Related]
5. A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.
Foka P; Dimitriadis A; Kyratzopoulou E; Giannimaras DA; Sarno S; Simos G; Georgopoulou U; Mamalaki A
Cell Mol Life Sci; 2014 Nov; 71(21):4243-58. PubMed ID: 24718935
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
Miura K; Taura K; Kodama Y; Schnabl B; Brenner DA
Hepatology; 2008 Nov; 48(5):1420-9. PubMed ID: 18671304
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
Hino K; Nishina S; Sasaki K; Hara Y
Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
[TBL] [Abstract][Full Text] [Related]
8. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
Hörl WH; Schmidt A
Nephrol Dial Transplant; 2014 Jun; 29(6):1141-4. PubMed ID: 24286977
[TBL] [Abstract][Full Text] [Related]
9. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus.
Liu H; Trinh TL; Dong H; Keith R; Nelson D; Liu C
PLoS One; 2012; 7(10):e46631. PubMed ID: 23110054
[TBL] [Abstract][Full Text] [Related]
10. Critical role of CREBH-mediated induction of transforming growth factor β2 by hepatitis C virus infection in fibrogenic responses in hepatic stellate cells.
Chida T; Ito M; Nakashima K; Kanegae Y; Aoshima T; Takabayashi S; Kawata K; Nakagawa Y; Yamamoto M; Shimano H; Matsuura T; Kobayashi Y; Suda T; Suzuki T
Hepatology; 2017 Nov; 66(5):1430-1443. PubMed ID: 28621467
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.
Armitage AE; Stacey AR; Giannoulatou E; Marshall E; Sturges P; Chatha K; Smith NM; Huang X; Xu X; Pasricha SR; Li N; Wu H; Webster C; Prentice AM; Pellegrino P; Williams I; Norris PJ; Drakesmith H; Borrow P
Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12187-92. PubMed ID: 25092293
[TBL] [Abstract][Full Text] [Related]
12. Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice.
Korenaga M; Nishina S; Korenaga K; Tomiyama Y; Yoshioka N; Hara Y; Sasaki Y; Shimonaka Y; Hino K
Liver Int; 2015 Apr; 35(4):1303-14. PubMed ID: 25156780
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
14. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis.
Hino K; Nishina S; Hara Y
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():93-8. PubMed ID: 24251712
[TBL] [Abstract][Full Text] [Related]
15. [How Histone Deacetylase 3 Controls Hepcidin Expression and Hepatitis C Virus Replication].
Shcherbakova AS; Kochetkov SN; Kozlov MV
Mol Biol (Mosk); 2023; 57(3):427-439. PubMed ID: 37326046
[TBL] [Abstract][Full Text] [Related]
16. ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2.
Traeger L; Gallitz I; Sekhri R; Bäumer N; Kuhlmann T; Kemming C; Holtkamp M; Müller JC; Karst U; Canonne-Hergaux F; Muckenthaler MU; Bloch DB; Olschewski A; Bartnikas TB; Steinbicker AU
Free Radic Biol Med; 2018 Dec; 129():127-137. PubMed ID: 30227271
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin in hepatocellular carcinoma.
Joachim JH; Mehta KJ
Br J Cancer; 2022 Jul; 127(2):185-192. PubMed ID: 35264787
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin and iron regulatory proteins coordinately regulate ferroportin 1 expression in the brain of mice.
Wang L; Liu X; You LH; Ci YZ; Chang S; Yu P; Gao G; Chang YZ
J Cell Physiol; 2019 May; 234(5):7600-7607. PubMed ID: 30370612
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of bone morphogenetic proteins and activins.
Eddowes LA; Al-Hourani K; Ramamurthy N; Frankish J; Baddock HT; Sandor C; Ryan JD; Fusco DN; Arezes J; Giannoulatou E; Boninsegna S; Chevaliez S; Owens BMJ; Sun CC; Fabris P; Giordani MT; Martines D; Vukicevic S; Crowe J; Lin HY; Rehwinkel J; McHugh PJ; Binder M; Babitt JL; Chung RT; Lawless MW; Armitage AE; Webber C; Klenerman P; Drakesmith H
Nat Microbiol; 2019 Feb; 4(2):339-351. PubMed ID: 30510168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
